Skip to main content

Vor Biopharma Inc.

VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001817229

In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Vor Biopharma Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of VOR: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders6971+2
Shares58.9M54.5M−4.42M (−7.5%)
Value$139.7M$54.5M−$85.2M (−61.0%)

New holders (23)

Institutions that held Vor Biopharma Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to VOR in Q2 2024
InstitutionSharesValue% of portfolio
Y-Intercept (Hong Kong) Ltd132,298$132.3K0.01%
Qube Research & Technologies Ltd95,367$95.4K0.00%
Centiva Capital, LP77,800$77.8K0.00%
Point72 Asia (Singapore) Pte. Ltd.63,262$63.3K0.01%
Cubist Systematic Strategies, LLC52,914$52.9K0.00%
Squarepoint Ops LLC52,287$52.3K0.00%
Paloma Partners Management Co35,100$35.1K0.00%
HRT Financial LP31,855$31.0K0.00%
Ground Swell Capital, LLC20,674$20.7K0.02%
Mirae Asset Global ETFs Holdings Ltd.19,524$19.5K0.00%
SEI Investments Co17,596$17.6K0.00%
Point72 (DIFC) Ltd14,402$14.4K0.00%
Virtu Financial LLC12,370$12.0K0.00%
Jump Financial, LLC11,328$11.3K0.00%
AQR Capital Management LLC11,204$11.2K0.00%
Catalyst Funds Management Pty Ltd9,800$9.80K0.00%
ProShare Advisors LLC5,111$5.11K0.00%
Federated Hermes, Inc.3,600$3.60K0.00%
Macquarie Group Ltd1,945$1.95K0.00%
Russell Investments Group, Ltd.1,231$1.23K0.00%
NBC Securities, Inc.1,000$1.00K0.00%
SRS Capital Advisors, Inc.528$5280.00%
Smartleaf Asset Management LLC102$1160.00%

Sold out (21)

Institutions that held Vor Biopharma Inc. at the end of Q1 2024 and filed for Q2 2024 without it.